Camurus

Lund, Sweden - 22 May 2025 - Camurus (NASDAQ STO: CAMX) will attend the Jefferies Global Healthcare Conference from 3-5 June 2025 in New York. President and CEO Fredrik Tiberg will present on 4 June at 12.50 pm ET with an update on the company's recent developments.

A webcast of the presentation can be accessed via:
https://wsw.com/webcast/jeff319/camx.st/2242512

For more information
Fredrik Joabsson, Chief Business Development Officer
Tel. +46 (0)70 776 17 37
ir@camurus.com

About Camurus
Camurus is an international, science-led biopharmaceutical company committed to developing and commercializing innovative, long-acting medicines for improving the lives of patients with severe and chronic diseases. New drug products with best-in-class potential are conceived based on the company's proprietary FluidCrystal^® technology and its extensive R&D expertise. The R&D pipeline includes products for the treatment of dependence, pain, cancer, and endocrine diseases. Camurus has operations across Europe, the US, and Australia, with headquarters in Lund, Sweden. The company's shares are listed on Nasdaq Stockholm under the ticker CAMX. For more information, visit www.camurus.com and LinkedIn.

This information was submitted for publication at 2:00 pm CET on 22 May 2025.